REFERENCES
- Oddens B, Guis F. L’observance et l’oubli de pilule en France en 1995. Contracept Fertil Sex 1996;24:290–6
- Rosenberg MJ, Waugh MS, Meehan TE. Use and mis- use of oral contraceptives: risk indicators for poor pill taking and discontinuation. Contraception 1995;51:283–8
- Rosenberg M, Waugh MS, Burnhill MS. Compliance, counseling and satisfaction with oral contraceptives: a prospective evaluation. Fam Plann Perspect 1998;30:89–92
- Rosenberg M, Waugh MS. Causes and consequences of oral contraceptive noncompliance. Am J Obstet Gynecol 1999;180:276–9
- Rosenberg MJ, Waugh MS, Long S. Unintended preg- nancies and use, misuse and discontinuation of oral contraceptives. J Reprod Med 1995;40:355–60
- Uzan M. Rapport sur la prévention et la prise en charge des grossesses des adolescentes. Ministère de l’emploi et de la solidarité; Novembre 1998. sante.gouv.fr
- Hapangama DK, Glasier AF, Baird DT. Noncompli- ance among a group of women using a novel method of contraception. Fertil Steril 2001;76:1196–201
- Childs M, Cayet J, Desnoyers E, Lagente JL. Les observatoires de la prise en charge du patient atteint d’une pathologie (ORP®) Vers l’établissement de nouveaux standards méthodologiques. Lett Pharmacol 1999;13:90–2
- Clark LR. Will the pill make me sterile? Concerns and strategies to improve adherence to hormonal contra- ceptive regimens in adolescent girls. J Pediatr Adolesc Gynecol 2001;14:153–62
- Hillard PJ. Oral contraception noncompliance: the extent of the problem. Adv Contracept 1992; 8(Suppl 1): 13–20
- Dardano KL, Burkman RT. Contraceptive compli- ance. Obstet Gynecol Clin North Am 2000;27:933–41
- Guillebaud J. Advising women on which pill to take. Br Med J 1995;311:1111–12
- Ruggiero RJ. Patient communication and counseling on contraception and hormone replacement therapy. Am J Manag Care 2001; 7(Suppl 18):S580–5
- Elomaa K, Rolland R, Brosens I, et al. Omitting the first oral contraceptive pills of the cycle does not automati- cally lead to ovulation. Am J Obstet Gynecol 1998; 179:41–6
- Spielmann D, the Gestodene Study Group 324. Cycle control, safety and efficacy of a 24-day regimen of gestodene 60 mg/ethinylestradiol 15 mg and a 21-day regimen of desogestrel 150 mg/ethinylestradiol 20 mg. Eur J Contracept Reprod Health Care 1999; 4(Suppl 2): 17–25
- Korver T, Goorisen E, Guillebaud J. The combined oral contraceptive pill: what advice should we give when tablets are missed? Br J Obstet Gynaecol 1995; 102:601–7
- Kubba A, Guillebaud J. Combined oral contraceptives: acceptability and effective use. Br Med Bull 1993;49:140–57
- Mills AM, Wilkinson CL, Bromham DR, et al. Guide- lines for prescribing combined oral contraceptives. Br Med J 1996;312:121–2